1,498 results on '"Sieper, Joachim"'
Search Results
52. Incorporation of the anteroposterior lumbar radiographs in the modified Stoke Ankylosing Spondylitis Spine Score improves detection of radiographic spinal progression in axial spondyloarthritis
53. Mechanism of New Bone Formation in Axial Spondyloarthritis
54. Synovial cell production of IL-26 induces bone mineralization in spondyloarthritis
55. Introduction
56. Introduction
57. Intraartikuläres Morphin bei Kniegelenksarthritis – Ergebnisse einer randomisierten placebokontrollierten Studie
58. Eine Therapie mit nicht-steroidalen Antirheumatika ist mit einer Verzögerung der radiografischen Progression der Wirbelsäule bei Patienten mit axialer Spondyloarthritis assoziiert: 10-Jahres-Ergebnisse der GErman SPondyloarthritis Inception Cohort
59. Vergleich des Effekts einer konsequenten Behandlung mit NSAIDs in Kombination mit einer Anti-TNF-Therapie im Vergleich zu einer alleinigen Anti-TNF-Therapie auf das Fortschreiten von strukturellen Schäden an der Wirbelsäule über einen Zeitraum von zwei Jahre bei Patienten mit ankylosierender Spondylitis (CONSUL) – eine offene, randomisierte, kontrollierte, multizentrische Studie
60. Höhere Vitamin-D-Spiegel sind mit einem besseren klinischen Ansprechen auf eine biologische Therapie bei Patienten mit axialer Spondyloarthritis verbunden: Ergebnisse der GESPIC-Kohorte
61. Geschichte der Biologikatherapie bei axialer Spondyloarthritis – Teil 2
62. Diagnostic evaluation of the sacroiliac joints for axial spondyloarthritis: should MRI replace radiography?
63. Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort
64. Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time‐Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10‐Year Results From the German Spondyloarthritis Inception Cohort
65. The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study
66. Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
67. Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
68. Axial spondyloarthropathies
69. Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort.
70. An explorative study on deep profiling of peripheral leukocytes to identify predictors for responsiveness to anti-tumour necrosis factor alpha therapies in ankylosing spondylitis: natural killer cells in focus
71. Do ethnicity, degree of family relationship, and the spondyloarthritis subtype in affected relatives influence the association between a positive family history for spondyloarthritis and HLA-B27 carriership? Results from the worldwide ASAS cohort
72. Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial
73. The role of B27 and other genes associated with ankylosing spondylitis
74. Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis
75. MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group
76. Reaktive Arthritis
77. Spondylitis ankylosans
78. Recent Advances in the Pharmacotherapy of Spondyloarthropathies
79. Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort
80. Treatment with Non-steroidal Anti-inflammatory Drugs Is Associated with Retardation of Radiographic Spinal Progression in Patients with Axial Spondyloarthritis: 10-year Results from the GErman SPondyloarthritis Inception Cohort
81. MRI Spinal Lesions in Patients Without MRI or Radiographic Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis
82. OP0149 Radiographic progression from non-radiographic to radiographic axial spondyloarthritis: results from a 5-year multicountry prospective observational study
83. Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: results from the SIMACT study
84. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA
85. Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study
86. Low Rate of Progression to Ankylosing Spondylitis Among Patients With Presumed Nonradiographic Axial Spondyloarthritis: Comment on the Article by Wang et al
87. Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study
88. What amount of structural damage defines sacroiliitis: a CT study
89. T cell responses in reactive and Lyme arthritis
90. List of contributors
91. A cluster analysis in the worldwide ASAS-PerSpA study
92. Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results
93. Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One‐Year Results of a Double‐Blind, Placebo‐Controlled Study and Open‐Label Extension
94. Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study
95. Five-year follow-up of radiographic sacroiliitis: progression as well as improvement?
96. Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis
97. New evidence on the management of spondyloarthritis
98. Course of Magnetic Resonance Imaging–Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods
99. Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study
100. Management of ankylosing spondylitis/axial spondyloarthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.